Microbot Medical Inc (MBOT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Microbot Medical Inc Stock (MBOT) Company Profile

Microbot Medical Inc

Healthcare (1110)

908-938-5561

25 RECREATION PARK DR SUITE 108, HINGHAM, MA

@microbotmedical

Nächster Verdiensttermin

Neueste SEC-Einreichungen

MBOT's Discussions on Twitter

Compare MBOT vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MBOT Microbot Medical Inc	1.80	114.85M	0	-13.14M	-13.11M	-0.3056
ISRG Intuitive Surgical Inc	437.67	155.16B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	148.84	40.68B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	67.71	33.06B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	36.13	31.30B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	208.57	30.18B	5.54B	1.52B	1.74B	10.37

Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-10	Eingeleitet	B. Riley Securities	Buy
2025-12-03	Eingeleitet	Roth Capital	Buy
2020-01-13	Bestätigt	H.C. Wainwright	Buy
2019-12-24	Bestätigt	H.C. Wainwright	Buy
2018-01-31	Eingeleitet	Ladenburg Thalmann	Buy

Microbot Medical Inc Aktie (MBOT) Neueste Nachrichten

Finanzdaten der Microbot Medical Inc-Aktie (MBOT)

Microbot Medical Inc (MBOT)

Microbot Medical Inc Stock (MBOT) Company Profile

Compare MBOT vs ISRG, BDX, ALC, MDLN, RMD

Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades

Microbot Medical Inc Aktie (MBOT) Neueste Nachrichten

Microbot Medical Inc. Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY Endovascular Robotic System - marketscreener.com

Microbot Medical receives Israel approval for robotic system By Investing.com - Investing.com Canada

Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System - The Manila Times

[8-K] Microbot Medical Inc. Reports Material Event - Stock Titan

Israel clears single-use LIBERTY vascular robot, opening new markets - Stock Titan

After plunging 22.6% in 4 weeks, here's why the trend might reverse for Microbot Medical (MBOT) - MSN

After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT) - Yahoo Finance

Microbot Medical Inc stock (US5950101098): Liberty launch drives first-quarter revenue and raises in - AD HOC NEWS

Microbot Medical Inc. (MBOT) reports Q1 loss, misses revenue estimates - MSN

Microbot Medical stock (US5950101098): Cash runway, pipeline, and what investors are watching - AD HOC NEWS

Microbot Medical (NASDAQ:MBOT) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Microbot Medical Inc stock (US5950101098): LIBERTY call and Q1 2026 numbers keep focus on robot-assi - AD HOC NEWS

Microbot Medical Schedules Call on LIBERTY System Progress - TipRanks

Microbot Medical to Host May 18 Call Addressing LIBERTY FMR Progress and Third‑Party Article - TradingView

Microbot Medical (NASDAQ: MBOT) sets investor call on LIBERTY progress and recent article - Stock Titan

Microbot Medical to host call addressing recent claims and progress of LIBERTY robotic system - Pluang

Microbot Medical Inc. to Host Conference Call Addressing Misrepresentations from Unaffiliated Third-Party Article - Quiver Quantitative

Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu - The Manila Times

Doctors using Microbot’s LIBERTY robot to address article claims - Stock Titan

Microbot Medical (MBOT) Reports Q1 Loss and Faces Short Seller S - GuruFocus

Microbot Medical (MBOT) Faces Stock Plunge Amid Short Seller Rep - GuruFocus

Microbot Medical Inc stock (US5950101098): shares under pressure after short-seller report and weak - AD HOC NEWS

Microbot Medical plunges amid results, short report from White Diamond Research - MSN

Microbot Medical Reports First Revenue from LIBERTY System as Commercial Adoption Accelerates Across U.S. Hospitals 1 - Minichart

Microbot Medical stock drops after White Diamond short report By Investing.com - Investing.com Australia

Microbot Medical stock drops after White Diamond short report - Investing.com

Microbot Medical Launches Full Commercial LIBERTY System Rollout - TipRanks

Microbot Medical Q2 revenue surpasses Q1 after system launch - Investing.com

Microbot Medical Q2 revenue surpasses Q1 after system launch By Investing.com - Investing.com Australia

Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System - TradingView

Microbot Medical records Q1 revenue; Q2 mid-quarter revenue already exceeds Q1 as LIBERTY adoption grows - TradingView

Microbot Medical (NASDAQ: MBOT) sees LIBERTY system revenue rise in Q2 - Stock Titan

Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026 - GlobeNewswire

Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com

Microbot Medical Inc. (MBOT) latest stock news and headlines - Yahoo Finance Singapore

Microbot Medical Inc. 1Q 2026: Revenue $105K, Net income $(3.67M) — 10-Q Summary - TradingView

Microbot Medical (NASDAQ: MBOT) starts LIBERTY robot sales with strong cash - Stock Titan

Microbot Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

MBOT Stock Price, Quote & Chart | MICROBOT MEDICAL INC (NASDAQ:MBOT) - ChartMill

TradingKey - TradingKey

MSN Money - MSN

Number of shareholders of Microbot Medical Inc. – NASDAQ:MBOT - TradingView

Microbot Medical Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday - MarketBeat

Microbot Medical’s LIBERTY System Gains Early Market Traction - TipRanks

Microbot Medical®'s Liberty® endovascular robotic system is now adopted by multiple accounts across key territories including two Access-PVI pivotal clinical trial sites - marketscreener.com

A blood-vessel robot lands 2 trial sites as its rollout expands - Stock Titan

Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites - TradingView

Microbot wins multiple LIBERTY system accounts, including two ACCESS-PVI trial sites - TradingView

Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites - marketscreener.com

Microbot Medical (MBOT) gains new LIBERTY robotic adopters post-SIR - Stock Titan

Finanzdaten der Microbot Medical Inc-Aktie (MBOT)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie MBOT